Cargando…
Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients
Thrombosis is one of the leading causes of mortality in cancer patients. The aim of the study was to evaluate the concentrations and activities of selected haemostatic parameters in the plasma of patients diagnosed with breast cancer (BrCa) and to make an attempt at finding associations with their l...
Autores principales: | Rhone, Piotr, Ruszkowska-Ciastek, Barbara, Bielawski, Kornel, Brkic, Alen, Zarychta, Elżbieta, Góralczyk, Barbara, Roszkowski, Krzysztof, Rość, Danuta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874264/ https://www.ncbi.nlm.nih.gov/pubmed/29475895 http://dx.doi.org/10.1042/BSR20171657 |
Ejemplares similares
-
Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes
por: Barbara, Ruszkowska-Ciastek, et al.
Publicado: (2020) -
Stromal Cell-Derived Factor 1α (SDF-1α) in Invasive Breast Cancer: Associations with Vasculo-Angiogenic Factors and Prognostic Significance
por: Zarychta, Elżbieta, et al.
Publicado: (2021) -
Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study
por: Ruszkowska-Ciastek, Barbara, et al.
Publicado: (2021) -
Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
por: Rhone, Piotr, et al.
Publicado: (2019) -
Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)